ProMIS Neurosciences, Inc. (PMN)
NASDAQ: PMN · Real-Time Price · USD
4.810
-6.270 (-56.59%)
Oct 30, 2026, 11:52 AM EDT - Market open
ProMIS Neurosciences Stock Forecast
PMN's stock price has decreased by -53.75% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 8 analysts polled by S&P Global, ProMIS Neurosciences stock has a consensus rating of "Strong Buy" and an average price target of $43.4. The average 1-year stock price forecast is 802.29% higher than the current stock price, while the lowest is $18.25 (+279.42%) and the highest is $99.56 (+1,969.85%).
Price Target: $43.4 (+802.29%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for ProMIS Neurosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 4 | 6 | 6 | 6 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 6 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $18 | Buy | Reiterates | $18 | +274.22% | Oct 15, 2026 |
| Roth MKM | Roth MKM | Buy Reiterates $30 → $29 | Buy | Reiterates | $30 → $29 | +502.91% | Aug 21, 2026 |
| Maxim Group | Maxim Group | Buy Maintains $35 | Buy | Maintains | $35 | +627.65% | Aug 15, 2026 |
| Guggenheim | Guggenheim | Buy Reiterates $69 → $100 | Buy | Reiterates | $69 → $100 | +1,979.00% | Aug 14, 2026 |
| Chardan Capital | Chardan Capital | Buy Maintains $33 | Buy | Maintains | $33 | +586.07% | Aug 14, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-5.23
EPS Next Year
-4.60
from -5.23
EPS and Forward PE are based on non-GAAP adjusted numbers.